These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29417292)

  • 21. Clinician-observed and patient-reported toxicities and their association with poor tolerance to therapy in older patients with head and neck or lung cancer treated with curative radiotherapy.
    Moon DH; Chera BS; Deal AM; Wang Y; Muss HB; VanderWalde NA
    J Geriatr Oncol; 2019 Jan; 10(1):42-47. PubMed ID: 29903673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The eating experience in long-term survivors of head and neck cancer: a mixed-methods study.
    Ganzer H; Rothpletz-Puglia P; Byham-Gray L; Murphy BA; Touger-Decker R
    Support Care Cancer; 2015 Nov; 23(11):3257-68. PubMed ID: 25851804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of unplanned admissions in head and neck cancer patients undergoing oncological treatment.
    Fahy E; Brooker RC; Fleming JC; Patterson JM
    Support Care Cancer; 2023 May; 31(6):328. PubMed ID: 37154829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tube feeding during treatment for head and neck cancer - Adherence and patient reported barriers.
    Brown T; Banks M; Hughes BGM; Lin C; Kenny L; Bauer J
    Oral Oncol; 2017 Sep; 72():140-149. PubMed ID: 28797450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lived experience of dysphagia following non-surgical treatment for head and neck cancer.
    Nund RL; Ward EC; Scarinci NA; Cartmill B; Kuipers P; Porceddu SV
    Int J Speech Lang Pathol; 2014 Jun; 16(3):282-9. PubMed ID: 24345002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.
    Lu W; Wayne PM; Davis RB; Buring JE; Li H; Macklin EA; Lorch JH; Burke E; Haddad TC; Goguen LA; Rosenthal DS; Tishler RB; Posner MR; Haddad RI
    Oncologist; 2016 Dec; 21(12):1522-1529. PubMed ID: 27511906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
    Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
    Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI.
    Rinkel RN; Verdonck-de Leeuw IM; Doornaert P; Buter J; de Bree R; Langendijk JA; Aaronson NK; Leemans CR
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1849-55. PubMed ID: 26071622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: a cross-sectional study.
    van den Berg MG; Rütten H; Rasmussen-Conrad EL; Knuijt S; Takes RP; van Herpen CM; Wanten GJ; Kaanders JH; Merkx MA
    Head Neck; 2014 Jan; 36(1):60-5. PubMed ID: 23559543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dental demineralization and caries in patients with head and neck cancer.
    Deng J; Jackson L; Epstein JB; Migliorati CA; Murphy BA
    Oral Oncol; 2015 Sep; 51(9):824-31. PubMed ID: 26198979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Zimmermann F; Betz M; Bodis S; Bernier J; Studer G; Aebersold DM;
    Radiother Oncol; 2012 Aug; 104(2):213-8. PubMed ID: 22726581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyoid bone displacement as parameter for swallowing impairment in patients treated for advanced head and neck cancer.
    Kraaijenga SA; van der Molen L; Heemsbergen WD; Remmerswaal GB; Hilgers FJ; van den Brekel MW
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):597-606. PubMed ID: 27086361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies.
    Kubicek GJ; Axelrod RS; Machtay M; Ahn PH; Anne PR; Fogh S; Cognetti D; Myers TJ; Curran WJ; Dicker AP
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1192-7. PubMed ID: 22245208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Chang PH; Yeh KY; Wang CH; Chen EY; Yang SW; Huang JS; Chou WC; Hsieh JC
    Head Neck; 2017 Oct; 39(10):1990-1996. PubMed ID: 28688124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.
    Zecha JA; Raber-Durlacher JE; Nair RG; Epstein JB; Elad S; Hamblin MR; Barasch A; Migliorati CA; Milstein DM; Genot MT; Lansaat L; van der Brink R; Arnabat-Dominguez J; van der Molen L; Jacobi I; van Diessen J; de Lange J; Smeele LE; Schubert MM; Bensadoun RJ
    Support Care Cancer; 2016 Jun; 24(6):2793-805. PubMed ID: 26984249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Tongue Strength and Maximum Incisal Opening with Oral Intake in Persons with Head and Neck Cancer Treated with Radiotherapy: A Retrospective Study.
    Pauloski BR; Nitschke T; Schultz S; Bloedel S; Amman A; Kessler L; Lisowski K
    Dysphagia; 2024 Aug; 39(4):726-734. PubMed ID: 38446254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
    Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake.
    Messing BP; Ward EC; Lazarus C; Ryniak K; Maloney J; Thompson CB; Kramer E
    Head Neck; 2021 Jul; 43(7):2159-2177. PubMed ID: 33856086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC.
    Moroney LB; Ward EC; Helios J; Crombie J; Burns CL; Blake C; Comans T; Chua B; Kenny L; Hughes BGM
    Support Care Cancer; 2020 Apr; 28(4):1867-1876. PubMed ID: 31352509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom experience and regaining normality in the first year following a diagnosis of head and neck cancer: a qualitative longitudinal study.
    Molassiotis A; Rogers M
    Palliat Support Care; 2012 Sep; 10(3):197-204. PubMed ID: 22613011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.